首页|期刊导航|中药新药与临床药理|肉桂醛调控糖酵解改善糖尿病肾病小鼠炎症反应及肾纤维化的作用机制

肉桂醛调控糖酵解改善糖尿病肾病小鼠炎症反应及肾纤维化的作用机制OA

Mechanism of Cinnamaldehyde in Ameliorating Inflammatory Response and Renal Fibrosis in Diabetic Kidney Disease Mice by Regulating Glycolysis

中文摘要英文摘要

目的 探讨肉桂醛调控糖酵解改善糖尿病肾病小鼠炎症反应及肾纤维化的作用机制.方法 (1)动物实验:采用高脂饲料喂养 6 周后连续 5 d腹腔注射链脲佐菌素(50 mg·kg-1)复制糖尿病肾病小鼠模型.将C57BL/6J小鼠随机分为正常组、模型组、肉桂醛组(10 mg·kg-1)、达格列净组(1 mg·kg-1),每组 8 只;灌胃给药,每日 1 次,连续 4 周;给药期间每周检测小鼠体质量、空腹血糖水平.计算小鼠肾脏指数,检测小鼠血清肾功能指标[肌酐(Scr)、尿素氮(BUN)]及血脂水平[甘油三酯(TC)、总胆固醇(TG)];收集小鼠尿液,检测尿微量白蛋白(mALB)水平;制备肾脏组织上清液,检测小鼠肾脏组织乳酸、三磷酸腺苷(ATP)水平;采用 HE、Masson、过碘酸-雪夫(PAS)染色法观察肾脏组织病理变化;RT-qPCR法检测肾脏组织TNF-α、IL-6、IL-1β、Col1a1、FN mRNA表达水平;Western Blot法检测肾脏组织 E-cadherin、N-cadherin、TGF-β、α-SMA、PKM2、LDHA蛋白表达水平.(2)细胞实验:以高糖(30 mmol·L-1)+10 μg·mL-1 LPS诱导小鼠肾小管上皮细胞(mRTECs)损伤(模型组)后,分别给予 10、20、40 μmol·L-1 肉桂醛及糖酵解抑制剂 2-DG(5 mmol·L-1)干预 24 h,采用CCK-8法检测细胞活性;采用 RT-qPCR 法检测细胞 TNF-α、IL-6、IL-1β、Col1a1、FN mRNA 表达水平;采用Western Blot法检测细胞PKM2、HK2、LDHA蛋白表达水平.结果 (1)与正常组比较,模型组小鼠的肾脏指数及空腹血糖、mALB水平显著升高(P<0.05,P<0.01);血清 Scr、BUN、TC、TG水平均显著升高(P<0.01);肾小球系膜增生,肾小管细胞排列紊乱、空泡变性、炎性细胞浸润;系膜基质增生明显,肾小球基底膜增厚,糖原沉积、胶原纤维沉积明显增多;肾脏组织TNF-α、IL-6、IL-1β、Col1a1、FN mRNA表达水平及N-cadherin、α-SMA、TGF-β蛋白表达水平均显著升高(P<0.05,P<0.01),E-cadherin蛋白表达水平明显降低(P<0.05);肾脏组织的乳酸水平显著升高(P<0.01),ATP水平显著降低(P<0.01),LDHA蛋白表达明显上调(P<0.05).与模型组比较,肉桂醛组及达格列净组小鼠的肾脏指数及mALB水平显著降低(P<0.01);血清Scr、BUN、TC、TG水平均显著降低(P<0.05,P<0.01);肾脏组织损伤有明显改善,炎性细胞浸润、糖原沉积及纤维化明显减轻;肾脏组织TNF-α、IL-6、IL-1β、Col1a1、FN mRNA表达水平及N-cadherin、TGF-β蛋白表达水平均显著降低(P<0.05,P<0.01),E-cadherin蛋白表达水平明显升高(P<0.05);肾脏组织乳酸水平明显降低(P<0.05),ATP水平明显升高(P<0.05),LDHA蛋白表达显著下调(P<0.05,P<0.01).(2)与低糖对照组比较,模型组mRTECs细胞活力显著降低(P<0.01),TNF-α、IL-6、IL-1β、Col1a1、FN mRNA表达水平显著升高(P<0.01),HK2蛋白表达明显上调(P<0.05).与模型组比较,10、20、40 μmol·L-1 肉桂醛组mRTECs细胞活力显著上升(P<0.05,P<0.01);40 μmol·L-1肉桂醛组及 2-DG组mRTECs细胞的TNF-α、IL-6、IL-1β、Col1a1、FN mRNA 表达水平显著降低(P<0.05,P<0.01),PKM2、HK2 蛋白表达显著下调(P<0.05,P<0.01).结论 肉桂醛可以改善糖尿病肾病小鼠的肾脏组织病理损伤,缓解炎症反应及肾纤维化,其机制可能与抑制糖酵解相关通路有关.

Objective To investigate the mechanism by which cinnamaldehyde regulates glycolysis to ameliorate inflammatory response and renal fibrosis in mice with diabetic kidney disease(DKD).Methods(1)Animal experiment:A DKD mouse model was established by feeding a high-fat diet for 6 weeks followed by intraperitoneal injection of streptozotocin(50 mg·kg-1)for 5 consecutive days.C57BL/6J mice were randomly divided into a normal group,a model group,a cinnamaldehyde group(10 mg·kg-1),and a dapagliflozin group(1 mg·kg-1),with 8 mice per group.Drugs were administered by gavage once daily for 4 weeks.Body weight and fasting blood glucose levels were measured weekly during the treatment period.The kidney index was calculated.Serum levels of renal function markers[creatinine(Scr)and blood urea nitrogen(BUN)]and lipid profiles[triglycerides(TG)and total cholesterol(TC)]were detected.Urine was collected for measurement of urinary microalbumin(mALB).Kidney tissue supernatant was prepared to determine the levels of lactate and adenosine triphosphate(ATP).Renal histopathological changes were observed by HE,Masson,and periodic acid-Schiff(PAS)staining.The mRNA expression levels of TNF-α,IL-6,IL-1β,Col1a1,and FN in kidney tissue were detected by RT-qPCR.The protein expression levels of E-cadherin,N-cadherin,TGF-β,α-SMA,PKM2,and LDHA in kidney tissue were detected by Western Blot.(2)Cell experiment:mouse renal tubular epithelial cells(mRTECs)were injured by high glucose(30 mmol·L-1)plus 10 μg·mL-1 LPS to establish the model group.The cells were treated with 10,20,or 40 μmol·L-1 cinnamaldehyde and the glycolysis inhibitor 2-deoxy-D-glucose(2-DG,5 mmol·L-1)for 24 hours.Cell viability was assessed by CCK-8 assay.The mRNA expression levels of TNF-α,IL-6,IL-1β,Col1a1,and FN were detected by RT-qPCR,and the protein expression levels of PKM2,HK2,and LDHA were detected by Western Blot.Results(1)Compared with the normal group,the model group exhibited significantly increased kidney index,fasting blood glucose,and mALB levels(P<0.05,P<0.01);significantly elevated serum levels of Scr,BUN,TG,and TC(P<0.01);mesangial proliferation,disordered arrangement of tubular epithelial cells,vacuolar degeneration,inflammatory cell infiltration,marked mesangial matrix expansion,thickened glomerular basement membrane,and obviously increased glycogen and collagen fiber deposition;significantly upregulated mRNA expression of TNF-α,IL-6,IL-1β,Col1a1,and FN,and protein expression of N-cadherin,α-SMA,and TGF-β(P<0.05,P<0.01),whereas E-cadherin protein expression was significantly decreased(P<0.05);markedly increased lactate level(P<0.01),significantly decreased ATP level(P<0.01),and significantly upregulated LDHA protein expression(P<0.05)in kidney tissue.Compared with the model group,both the cinnamaldehyde group and the dapagliflozin group showed significantly reduced kidney index and mALB level(P<0.01);significantly decreased serum levels of Scr,BUN,TG,and TC(P<0.05,P<0.01);obviously ameliorated renal pathological injury with attenuated inflammatory cell infiltration,glycogen deposition,and fibrosis;significantly downregulated mRNA expression of TNF-α,IL-6,IL-1β,Col1a1,and FN,and protein expression of N-cadherin and TGF-β(P<0.05,P<0.01),whereas E-cadherin protein expression was significantly increased(P<0.05);remarkably reduced lactate level(P<0.05),elevated ATP level(P<0.05),and significantly downregulated LDHA protein expression(P<0.05,P<0.01)in kidney tissue.(2)Compared with the low-glucose control group,the model group showed significantly decreased mRTECs viability(P<0.01),significantly increased mRNA expression of TNF-α,IL-6,IL-1β,Col1a1,and FN(P<0.01),and significantly upregulated HK2 protein expression(P<0.05).Compared with the model group,10,20,and 40 μmol·L-1 cinnamaldehyde significantly increased mRTECs viability(P<0.05,P<0.01);the 40 μmol·L-1 cinnamaldehyde group and the 2-DG group exhibited significantly reduced mRNA expression of TNF-α,IL-6,IL-1β,Col1a1,and FN(P<0.05,P<0.01),and significantly downregulated PKM2 and HK2 protein expression(P<0.05,P<0.01).Conclusion Cinnamaldehyde can ameliorate renal pathological injury,and alleviate inflammatory response and renal fibrosis in DKD mice,the mechanism of which may be associated with the inhibition of glycolysis-related pathways.

王芳婷;李杰鸿;王欢欢;张红妹;周玖瑶;吴俊标

广州中医药大学深圳医院(福田),广东 深圳 518034||广州中医药大学第二临床医学院,广东 广州 510006广州中医药大学第二临床医学院,广东 广州 510006广州中医药大学第二临床医学院,广东 广州 510006广州中医药大学第二临床医学院,广东 广州 510006广州中医药大学中药学院,广东 广州 510006广州中医药大学深圳医院(福田),广东 深圳 518034

医药卫生

肉桂醛糖尿病肾病炎症反应肾纤维化糖酵解肾小管上皮细胞小鼠

cinnamaldehydediabetic kidney diseaseinflammatory responserenal fibrosisglycolysismRTECsmice

《中药新药与临床药理》 2026 (8)

1407-1416,10

国家自然科学基金资助项目(82474174)广州市科技计划项目(2024A03J0054).

10.19378/j.issn.1003-9783.2026.08.002

评论